All four papers demonstrated that VEGF significantly rises at the time of a thrombotic event, with the percentage difference in VEGF levels between those with and without thrombosis of 17.3 and 63.4% across the four studies. The gene discussed is VEGFA; the disease is Venous thrombosis.